System Transmission

Top Signal

100#1 JOB

Activity

2168Ripe

+924 today

System

Livenow

Terminal Asset View

stockNASDAQ

IMNN

$2.99-4.78%

Imunon Inc

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

27Overripe

Live Analysis Active

Company Mission

Imunon Inc creates cancer therapies using DNA technology to target tumors more precisely. Hospitals and patients use these treatments because they aim to be safer and more effective than traditional options. The company makes money by conducting clinical trials, securing grants, and forming partnerships with bigger drug companies to develop and sell its products.

IMN

Industry Context

This company operates in the biotechnology sector, focusing on developing novel therapies for diseases like cancer. It competes with larger pharmaceutical firms by specializing in DNA-based treatments, which can offer targeted approaches with fewer side effects. The industry is driven by research breakthroughs and regulatory approvals, making clinical trial results critical for success.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

81Matrix

Market Momentum

36.8— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

1.2x— Normal Volume

Today's Change

-4.78%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing IMNN across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 12:30 AM UTC

As-of As of 2026-03-16T00:15:32.101Z UTC (~15m delay).

Develops cancer treatments using gene therapy to target tumors more precisely than traditional methods, aiming to improve patient outcomes.

Weekly volatility is tightening near , a classic setup for a larger move as price consolidates. Watch for a breakout above or below $3.00.

Industry trend of biotech innovation is driving interest, with price holding above $3.00, signaling resilience. Watch for sector momentum from FDA approvals.

Volume spiked 3x at $1, indicating buyer interest because of positive trial news. Monitor if volume stays above average near this level.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...